Trial intelligence / Profile preview

Remimazolam with butorphanol for anesthesia in hysteroscopic surgery

ChiCTR2100049786Phase 4Not yet recruiting

Sponsor
Jingmen First People's Hospital
Start
Jul 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of remimazolam (3 arms), sponsored by Jingmen First People's Hospital. Primary endpoints: Mean arterial pressure, Respiratory rate and 3 more. Planned start Jul 2021; status: not yet recruiting.

02

Drugs

remimazolam

Beyond the preview

Go deeper on ChiCTR2100049786.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2100049786.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call